Clinical Trial Research Updates

Weekly plain-language updates on clinical trial activity, written for patients and caregivers. TrialsAlert publishes research updates every Friday covering the most notable trials across all monitored conditions.

What are clinical trial research updates?

Clinical trial research updates are weekly summaries of new and updated clinical trials published on ClinicalTrials.gov, the world's largest registry of clinical studies. Each update covers a specific medical specialty or condition, highlighting the most significant trials from the past week. Our AI scores each trial across six dimensions — phase importance, breakthrough potential, patient accessibility, condition prevalence, sponsor credibility, and relevance — then classifies them as breakthrough, notable, or routine. The resulting briefings explain what changed, who is sponsoring the research, what phase it is in, and why it matters for patients, all in plain English without medical jargon. These updates serve patients, caregivers, and support communities who want to stay informed about clinical research without spending hours searching databases themselves.

Recent Updates

Rare Diseases Clinical Trials Update: Week 32, 2026

August 7, 2026 — 4 trials covered | Rare Diseases

Stem Cell Gene Therapy for Cystinosis This Phase 1/2 trial led by the University of California, San Diego explored a new gene therapy approach for cystinosis, a rare genetic disorder that affects how ...

Immunology Clinical Trials Update: Week 32, 2026

August 7, 2026 — 5 trials covered | Immunology

Randomized Stepped Wedge Study of Emapalumab in APECED Enteritis This Phase 2 trial is investigating emapalumab as a treatment for APECED enteritis, a rare autoimmune condition where the immune system...

Urology Clinical Trials Update: Week 32, 2026

August 7, 2026 — 5 trials covered | Urology

Active Surveillance Versus Adjuvant Intravesical Chemotherapy in Liquid Biopsy-Defined Low-Shedding Intermediate-Risk NMIBC This trial is exploring whether some patients with intermediate-risk non-mus...

Autoimmune & Rheumatology Clinical Trials Update: Week 32, 2026

August 7, 2026 — 5 trials covered | Autoimmune & Rheumatology

A Study of the Efficacy and Safety of SHR-1314 for Adult Active Psoriatic Arthritis This Phase III trial is testing a new injection called SHR-1314 for adults with active psoriatic arthritis, a condit...

Kidney Disease & Nephrology Clinical Trials Update: Week 32, 2026

August 7, 2026 — 5 trials covered | Kidney Disease & Nephrology

FXS6837 for the Treatment for IgAN Patients(Longterm Study) This Phase 2 study is testing the long-term safety and effectiveness of FXS6837 capsules in patients with primary IgA nephropathy, a common ...

Eye Disease & Ophthalmology Clinical Trials Update: Week 32, 2026

August 7, 2026 — 5 trials covered | Eye Disease & Ophthalmology

A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD This Phase 2 trial is testing GAL-101 eye drops for patients wi...

Skin Conditions & Dermatology Clinical Trials Update: Week 32, 2026

August 7, 2026 — 5 trials covered | Skin Conditions & Dermatology

A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD) This Phase 3 study ...

Lung & Respiratory Disease Clinical Trials Update: Week 32, 2026

August 7, 2026 — 5 trials covered | Lung & Respiratory Disease

ARrest RESpiraTory Failure From PNEUMONIA This Phase 3 trial tested an inhaled combination treatment for patients hospitalized with pneumonia who had low oxygen levels. The treatment aimed to prevent ...

Infectious Disease Clinical Trials Update: Week 32, 2026

August 7, 2026 — 5 trials covered | Infectious Disease

Azithromycin for Child Survival in Niger: Mortality and Resistance Trial This Phase 4 trial tested giving azithromycin to children under five years old in Niger every six months. The goal was to see i...

Women's Health & Gynecology Clinical Trials Update: Week 32, 2026

August 7, 2026 — 5 trials covered | Women's Health & Gynecology

Bupropion for the Prevention of Postpartum Smoking Relapse A Phase 4 trial led by the University of Minnesota tested whether the medication bupropion can help new mothers avoid starting smoking again ...

Blood Disorders & Hematology Clinical Trials Update: Week 32, 2026

August 7, 2026 — 5 trials covered | Blood Disorders & Hematology

A Study Comparing a New Drug (Surovatamig) With Standard Radiotherapy With or Without Rituximab in Adults With Limited Stage Nodal Follicular Lymphoma This upcoming phase 3 trial will compare a new dr...

Pediatrics & Child Health Clinical Trials Update: Week 32, 2026

August 7, 2026 — 5 trials covered | Pediatrics & Child Health

Comparing Esketamine and Remazolam With Propofol for Breathing Safety in Pediatric Gastroscopy This study is testing a new combination of sedative medicines called esketamine and remimazolam for child...

Mental Health & Psychiatry Clinical Trials Update: Week 32, 2026

August 7, 2026 — 5 trials covered | Mental Health & Psychiatry

Mindfulness-Assisted Psychedelic Therapy This Phase 2 trial from the University of Southern California is exploring a combination of psilocybin, a psychedelic compound, with mindfulness training in he...

Diabetes & Endocrinology Clinical Trials Update: Week 32, 2026

August 7, 2026 — 5 trials covered | Diabetes & Endocrinology

EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway This Phase 3 trial explored the use of setmelanotide, a medication designed for people with obesity caused...

Orthopedics & Musculoskeletal Clinical Trials Update: Week 32, 2026

August 7, 2026 — 5 trials covered | Orthopedics & Musculoskeletal

iFuse TORQ for the Treatment of Sacroiliac Joint Dysfunction This Phase 4 trial tests the iFuse TORQ implant system for adults with sacroiliac joint dysfunction, a condition that causes pain in the lo...

Heart Disease & Cardiology Clinical Trials Update: Week 32, 2026

August 7, 2026 — 5 trials covered | Heart Disease & Cardiology

A Study to Evaluate Mavacamten Impact on Myocardial Structure in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy This Phase 4 study is looking at how the drug mavacamten affects ...

Neurology & Brain Disorders Clinical Trials Update: Week 32, 2026

August 7, 2026 — 5 trials covered | Neurology & Brain Disorders

Outcomes After Planned Discontinuation of AntiSeizure Medication This Phase 4 trial from the University of Michigan is exploring what happens when people with epilepsy who have been seizure-free stop ...

Immunology Clinical Trials Update: Week 27, 2026

July 3, 2026 — 5 trials covered | Immunology

Study on the Treatment of Adolescent Patients With Seasonal Allergic Rhinitis This Phase 3 trial is testing a new injection called Stapokibart for adolescents suffering from seasonal allergic rhinitis...

Autoimmune & Rheumatology Clinical Trials Update: Week 27, 2026

July 3, 2026 — 5 trials covered | Autoimmune & Rheumatology

3TR (Taxonomy, Treatment, Targets and Remission) Systemic Lupus Erithematosus Study Protocol This Phase 3 study is exploring a new way to predict flare-ups in people with systemic lupus erythematosus ...

Urology Clinical Trials Update: Week 27, 2026

July 3, 2026 — 5 trials covered | Urology

A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT This Phase 3 trial is exploring a new treatment called cretostimogene grenadenorepvec for pa...

Eye Disease & Ophthalmology Clinical Trials Update: Week 27, 2026

July 3, 2026 — 5 trials covered | Eye Disease & Ophthalmology

Fenofibrate for Prevention of DR Worsening This Phase 3 trial by the Jaeb Center for Health Research is studying fenofibrate, a pill taken by mouth, to see if it can stop diabetic retinopathy from get...

Kidney Disease & Nephrology Clinical Trials Update: Week 27, 2026

July 3, 2026 — 5 trials covered | Kidney Disease & Nephrology

Glucagon-like-peptide-1 Receptor Agonists in Patients Receiving Maintenance Dialysis This Phase 4 trial by Unity Health Toronto is studying semaglutide, a once-weekly injection, in people with diabete...

Rare Diseases Clinical Trials Update: Week 27, 2026

July 3, 2026 — 5 trials covered | Rare Diseases

AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD) This Phase 2 trial is testing a gene therapy called RGX-202 for boys with Duchenne Muscular Dystrophy, a ...

Skin Conditions & Dermatology Clinical Trials Update: Week 27, 2026

July 3, 2026 — 5 trials covered | Skin Conditions & Dermatology

A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon) This Phase 3 study evaluated rocatinlimab, a new targeted treatment for adults with m...

Women's Health & Gynecology Clinical Trials Update: Week 27, 2026

July 3, 2026 — 5 trials covered | Women's Health & Gynecology

Period Pills for Menstrual Regulation: A New Reproductive Health Option This study by the University of California, San Francisco is exploring a new option for managing menstrual cycles using pills th...

Lung & Respiratory Disease Clinical Trials Update: Week 27, 2026

July 3, 2026 — 5 trials covered | Lung & Respiratory Disease

A Study of Depemokimab in Participants of 6 to 11 Years of Age This Phase 3 study is exploring depemokimab as an additional treatment for children aged 6 to 11 with asthma linked to type 2 inflammatio...

Pediatrics & Child Health Clinical Trials Update: Week 27, 2026

July 3, 2026 — 5 trials covered | Pediatrics & Child Health

Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm Infants This Phase 3 trial studied the drug darbepoetin in 650 preterm infants across 16 U.S. sites to see if it can support b...

Blood Disorders & Hematology Clinical Trials Update: Week 27, 2026

July 3, 2026 — 5 trials covered | Blood Disorders & Hematology

Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome This phase 3 trial compare...

Subscribe to get weekly briefings for your specific condition.